Skip to main content
The Bright Side
arrow_backHome
US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms
Health
Good News NetworkEN
August 25, 2026

US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms

A Japanese pharma company has developed a drug that treats the root cause of a leading form of narcolepsy, and is celebrating as it becomes the first of its kind to receive American FDA approval. Narcolepsy type-1 afflicts 120,000 people in the US, and is characterized by sudden bouts of intense daytime drowsiness, disrupted nighttime […] The post US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms appeared first on Good News Network.

Read More

Curated from Good News Network. Classified as Health by AI, which sometimes makes mistakes.

Why are you reporting this article?

Why are you reporting this article?
0/500

More like this

More
Walla! Health News8/27/2026

With full genomic sequencing at Sheba: the revolutionary technology that eliminates excess weight and extends life by up to an additional 30 years

23 years after the Human Genome Project was completed, Israeli scientists have succeeded in translating this knowledge into a technology that allows every person to lose weight permanently, be saved from thousands of diseases, including 50 types of cancer, and extend life by several decades. Prof. Barbash: "We are at a turning point in medicine"

Ynet Health8/27/2026

"I couldn't believe it": Innovative blood test raised suspicion of cancer — and imaging revealed a lung mass

Large-scale research found that combining the “Grail” blood test with standard screening examinations could increase the number of detected cancer cases fourfold. The same happened to Peter, a retired police officer from England, who, following the test and subsequent diagnostic examinations, discovered that he is developing lung cancer. “I had no symptoms at all. I didn't feel sick,” he says. The “Grail” test is an innovative blood test designed to detect signals of 50 types of cancer before symptoms appear.